304-24: Pharmacology of Obesity and the Intersection with Psychopharmacology

5 (1 vote)

  • Register
    • Non-member - $25
    • Regular Member - $15
    • Retired Member - $15
    • Affiliate Member - $15
    • Student Member - $15

Internet Explorer does not cooperate well with this platform. Please see below for options that work with APNA eLearning Center programs.*


304-24: Pharmacology of Obesity and the Intersection with Psychopharmacology 

Review current anti-obesity medications and, through case studies that include patients with depression, anxiety, and severe mental illness, examine the intersection of obesity and mental illness.


Presenter:
  Angela Golden, DNP, FNP-C, FAANP, FOMA

Disclosures:  The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationships to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will not be discussed during this presentation.

Angela Golden, DNP, FNP-C, FAANP, FOMA is a promotional speaker for Novo Nordisk, Acella Pharmaceuticals, Currax Pharmaceuticals and Eli Lilly. Dr. Golden is on the advisory board for Boehringer-Ingelheim, WW, Novo Nordisk, Acella Pharmaceuticals, Currax Pharmaceuticals and Eli Lilly. During the last 24 months, Dr. Golden was on the advisory board for Gelesis (this financial relationship has ended). 


Session Length:
  1 hour 30 minutes

Target Audience:  RN, APRN


Learning Outcome:
Upon completion of this presentation, the participant will be able to:

  • Recognize the impact of psychiatric medications on obesity and treatment options for reducing the weight gain associated with psychiatric medications.

Course Outcome:

  • 65% of learners will report an intent to make changes to their practice as a result of completing this course. 

Keywords:  Obesity, Psychiatric Medications, Weight Gain, Mental Disorders, Antipsychotic Medications, Obesogenic Medications, Diet, Physical Activity, Exercise, Healthy Eating


Nursing Continuing Professional Development:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


Release date: July 8, 2024
Access to this course will end:
July 31, 2026

© 2024 APNA. Reproducing and distributing this material without the written permission of the American Psychiatric Nurses Association (APNA) is prohibited. 

*For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

Components visible upon registration.